BRIEF published on 05/10/2024 at 18:05, 2 years 5 months ago Medincell annonce les détails sur le capital et les droits de vote conformément à la réglementation Euronext Paris Droits De Vote Réglementation Financière Capital Social Medincell
BRIEF published on 05/10/2024 at 18:05, 2 years 5 months ago Medincell announces details on capital and voting rights in accordance with regulations Euronext Paris Share Capital Voting Rights Financial Regulation Medincell
PRESS RELEASE published on 05/10/2024 at 18:00, 2 years 5 months ago Informations privilégiées / Autres communiqués Annonce mensuelle des actions et droits de vote de Medincell sur Euronext Paris. Medincell développe des médicaments injectables à action prolongée pour divers domaines thérapeutiques Euronext Paris AMF Biopharmaceutique Medincell Médicaments Injectables
BRIEF published on 05/08/2024 at 12:35, 2 years 5 months ago Résultats Positifs pour l'Essai Phase 3 SOLARIS sur l’Olanzapine Schizophrénie Medincell TEV-‘749 SOLARIS Olanzapine
BRIEF published on 05/08/2024 at 12:35, 2 years 5 months ago Positive Results for the SOLARIS Phase 3 Trial of Olanzapine Schizophrenia Medincell SOLARIS Olanzapine TEV-'749
PRESS RELEASE published on 05/08/2024 at 12:30, 2 years 5 months ago Informations privilégiées / Autres communiqués Les résultats positifs de l'étude de phase 3 SOLARIS démontrent l'efficacité de TV-749, injection sous-cutanée mensuelle pour la schizophrénie par Teva et Medincell Santé Mentale Schizophrénie Medincell TV-749 Teva
PRESS RELEASE published on 05/08/2024 at 12:30, 2 years 5 months ago Inside Information / Other news releases Teva and Medincell announce positive Phase 3 efficacy results from SOLARIS trial evaluating TEV-'749 (olanzapine) as a once-monthly subcutaneous long-acting injectable in adults with schizophrenia Schizophrenia Medincell Teva Phase 3 Efficacy Results SOLARIS Trial
BRIEF published on 05/08/2024 at 09:05, 2 years 5 months ago Medincell Temporarily Suspends its Euronext Paris Listing Euronext Paris Press Release Financial Markets Medincell Share Suspension
BRIEF published on 05/08/2024 at 09:05, 2 years 5 months ago Medincell suspend temporairement sa cotation sur Euronext Paris Euronext Paris Marchés Financiers Communiqué De Presse Médine Partager La Suspension
PRESS RELEASE published on 05/08/2024 at 09:00, 2 years 5 months ago Inside Information / Other news releases Medincell suspends listing of shares on Euronext Paris pending press release. Innovative biopharmaceutical company developing long-acting injectable drugs Euronext Paris Biopharmaceutical Suspension Medincell Long-acting Injectable Drugs
Published on 10/30/2026 at 20:47, 1 hour 26 minutes ago CoTec Holdings Corp. Comments on Share Trading
Published on 10/30/2026 at 19:00, 3 hours 13 minutes ago Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 6 hours 43 minutes ago Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Published on 10/30/2026 at 12:20, 9 hours 53 minutes ago Silver X Files NI 43-101 Technical Report for the Updated Nueva Recuperada Mineral Resource: 10.4 Mt Measured and Indicated at 202 g/t AgEq (67.3 Moz AgEq) and 21.6 Mt Inferred at 260 g/t AgEq (184.3 Moz AgEq)
Published on 10/30/2026 at 12:00, 10 hours 13 minutes ago Aztec Minerals Strengthens Technical Management Team
Published on 10/30/2026 at 18:38, 3 hours 35 minutes ago EQS-Adhoc: Starcom Holding AD publishes Interim Q3 2026 Financial Report
Published on 10/30/2026 at 18:35, 3 hours 38 minutes ago EQS-Adhoc: hep global GmbH expects to conclude refinancing negotiations only in fiscal year 2027
Published on 10/30/2026 at 18:05, 4 hours 8 minutes ago lePERMISLIBRE divise par trois sa perte d’exploitation au premier semestre 2026
Published on 10/30/2026 at 18:00, 4 hours 13 minutes ago 2026 half-year earnings & third quarter revenue
Published on 10/30/2026 at 18:00, 4 hours 13 minutes ago Laboratoires Euromedis - Communiqué résultat semestriel 2026
